- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 3 x BLA: BILIVERDINE IX ALPHA(Non-covalent)
BLA.16: 11 residues within 4Å:- Chain A: N.90, I.92, R.93, W.95, I.110, N.112, V.117, M.168, R.181, F.183, L.217
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:N.90, A:R.93, A:W.95, A:I.110, A:N.112, A:V.117, A:F.183, A:L.217, A:L.217
- Hydrogen bonds: A:N.112
- pi-Cation interactions: A:R.181
BLA.32: 11 residues within 4Å:- Chain B: N.90, I.92, R.93, W.95, I.110, N.112, V.117, M.168, R.181, F.183, L.217
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:N.90, B:R.93, B:W.95, B:I.110, B:N.112, B:V.117, B:F.183, B:L.217, B:L.217
- Hydrogen bonds: B:N.112
- pi-Cation interactions: B:R.181
BLA.47: 11 residues within 4Å:- Chain C: N.90, I.92, R.93, W.95, I.110, N.112, V.117, M.168, R.181, F.183, L.217
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:N.90, C:R.93, C:W.95, C:I.110, C:N.112, C:V.117, C:F.183, C:L.217, C:L.217
- Hydrogen bonds: C:N.112
- pi-Cation interactions: C:R.181
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.17: 2 residues within 4Å:- Chain A: N.322, Q.571
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain A: E.300, N.594
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: N.607, T.609
Ligand excluded by PLIPNAG.20: 1 residues within 4Å:- Chain A: N.648
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain A: N.700
Ligand excluded by PLIPNAG.22: 5 residues within 4Å:- Chain A: A.697, E.1063, K.1064, N.1065
- Chain C: Q.886
Ligand excluded by PLIPNAG.23: 4 residues within 4Å:- Chain A: N.1089, T.1091, H.1092, F.1094
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain A: N.156
- Chain B: Y.342
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: N.271, E.272, N.273
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain A: G.330, N.334, S.362
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain A: N.8, N.128
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain A: Y.19, N.52
Ligand excluded by PLIPNAG.30: 6 residues within 4Å:- Chain A: H.137, N.139, N.140, S.142, W.143, M.144
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: N.322, Q.571
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain B: E.300, N.594
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain B: N.607, T.609
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain B: N.648
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain B: N.700
Ligand excluded by PLIPNAG.38: 5 residues within 4Å:- Chain A: Q.886
- Chain B: A.697, E.1063, K.1064, N.1065
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain B: N.1089, T.1091, H.1092, F.1094
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain B: N.156
- Chain C: Y.342
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain B: N.271, E.272, N.273
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain B: G.330, N.334, S.362
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain B: N.8, N.128
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain B: Y.19, N.52
Ligand excluded by PLIPNAG.46: 6 residues within 4Å:- Chain B: H.137, N.139, N.140, S.142, W.143, M.144
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain C: N.322, Q.571
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain C: E.300, N.594
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: N.607, T.609
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.648
Ligand excluded by PLIPNAG.52: 1 residues within 4Å:- Chain C: N.700
Ligand excluded by PLIPNAG.53: 5 residues within 4Å:- Chain B: Q.886
- Chain C: A.697, E.1063, K.1064, N.1065
Ligand excluded by PLIPNAG.54: 4 residues within 4Å:- Chain C: N.1089, T.1091, H.1092, F.1094
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain A: Y.342
- Chain C: N.156
Ligand excluded by PLIPNAG.56: 3 residues within 4Å:- Chain C: N.271, E.272, N.273
Ligand excluded by PLIPNAG.57: 3 residues within 4Å:- Chain C: G.330, N.334, S.362
Ligand excluded by PLIPNAG.58: 2 residues within 4Å:- Chain C: N.8, N.128
Ligand excluded by PLIPNAG.59: 2 residues within 4Å:- Chain C: Y.19, N.52
Ligand excluded by PLIPNAG.60: 6 residues within 4Å:- Chain C: H.137, N.139, N.140, S.142, W.143, M.144
Ligand excluded by PLIP- 3 x EIC: LINOLEIC ACID(Non-covalent)
EIC.27: 17 residues within 4Å:- Chain A: P.328, F.329, V.332, I.349, Y.356, L.359, Y.360, F.365, F.368, F.383, I.425, L.504, F.506
- Chain B: R.399, Q.400, T.406, G.407
18 PLIP interactions:16 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:F.329, A:F.329, A:V.332, A:I.349, A:Y.356, A:Y.356, A:L.359, A:Y.360, A:F.365, A:F.365, A:F.368, A:F.368, A:F.383, A:I.425, A:L.504, A:F.506
- Hydrogen bonds: B:Q.400
- Salt bridges: B:R.399
EIC.31: 17 residues within 4Å:- Chain A: R.399, Q.400, T.406, G.407
- Chain C: P.328, F.329, V.332, I.349, Y.356, L.359, Y.360, F.365, F.368, F.383, I.425, L.504, F.506
18 PLIP interactions:16 interactions with chain C, 2 interactions with chain A- Hydrophobic interactions: C:F.329, C:F.329, C:V.332, C:I.349, C:Y.356, C:Y.356, C:L.359, C:Y.360, C:F.365, C:F.365, C:F.368, C:F.368, C:F.383, C:I.425, C:L.504, C:F.506
- Hydrogen bonds: A:Q.400
- Salt bridges: A:R.399
EIC.43: 16 residues within 4Å:- Chain B: P.328, F.329, V.332, I.349, Y.356, L.359, Y.360, F.365, F.368, F.383, I.425, L.504, F.506
- Chain C: R.399, T.406, G.407
18 PLIP interactions:16 interactions with chain B, 2 interactions with chain C- Hydrophobic interactions: B:F.329, B:F.329, B:V.332, B:I.349, B:Y.356, B:Y.356, B:L.359, B:Y.360, B:F.365, B:F.365, B:F.368, B:F.368, B:F.383, B:I.425, B:L.504, B:F.506
- Hydrogen bonds: C:Q.400
- Salt bridges: C:R.399
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xiong, X. et al., A thermostable, closed SARS-CoV-2 spike protein trimer. Nat.Struct.Mol.Biol. (2020)
- Release Date
- 2020-07-22
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 3 x BLA: BILIVERDINE IX ALPHA(Non-covalent)
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 3 x EIC: LINOLEIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xiong, X. et al., A thermostable, closed SARS-CoV-2 spike protein trimer. Nat.Struct.Mol.Biol. (2020)
- Release Date
- 2020-07-22
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C